VEEVA Aktie

 

VEEV's strong second-quarter results, Vault CRM migrations and AI expansion support growth, while market saturation remains a key concern....

Steigende Renditen am Anleihemarkt und eine zunehmende Zurückhaltung der Anleger setzen wachstumsstarke Aktien unter Druck. Dennoch bieten Unternehmen mit innovativen Produkten und stabilen Wachstumsperspektiven weiterhin Chancen. Besonders Grail und Veeva Systems könnten sich trotz des schwierigen Marktumfelds als interessante Kandidaten für langfristig orientierte Anleger erweisen. Grail-Aktie: FDA-Zulassung voraus Grail entwickelt und vermarktet mit Galleri einen […] The post Momentum-Aktien: Diese 2 Börsenstars könnten ihren Höhenflug fortsetzen first appeared on sharedeals.de....

Was unsere Meinung zur Veeva Systems-Aktie stärkt, ist weniger das Umsatzwachstum von 18 % als die zunehmende Tiefe der Plattform. Der Artikel Deep Dive zur Veeva-Aktie: Die versteckten Potenziale, die keiner sieht ist zuerst erschienen auf Aktienwelt360....

Grail and Veeva Systems could be well insulated from near-term headwinds....

Eli Lilly and Company, Pfizer, Sanofi, UCB, and more share learnings speeding drug development, connecting trials, and modernizing quality and manufacturing PLEASANTON, Calif., Oct. 8, 2026 /PRNewswire/ -- At Veeva R&D and Quality Summit on October 20-21 in Boston, Veeva Systems (NYSE:......

VEEV's DQS cleans clinical trial data for over 1 million subjects across 1,000+ studies, expanding automation in clinical data management....

More than 175 biotechs use pre-configured applications to streamline operations PLEASANTON, Calif., Oct. 7, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 175 emerging biotechs are establishing a technology foundation with Veeva Basics. Biotechs are......

Automates data reconciliation, saving clinical teams significant cost, time, and effort PLEASANTON, Calif., Oct. 6, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Veeva DQS (Data Quality System) has aggregated and cleaned data for more than 1 million subjects in more......

Rizzo, Daniel J. - Vorstand - Tag der Transaktion: 2026-10-02...

Veeva Systems (VEEV) reached $273.25 at the closing of the latest trading day, reflecting a -3.08% change compared to its last close....

Veeva Systems (VEEV) closed the most recent trading day at $281.93, moving 1.23% from the previous trading session....

Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock....

Establishing an AI-ready data foundation in more than 80 countries PLEASANTON, Calif., Sept. 30, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Servier is standardizing customer reference data across more than 80 countries with Veeva OpenData. Building on its global......

Veeva Systems (VEEV) closed the most recent trading day at $280.68, moving +2.12% from the previous trading session....

VEEV's AI-powered Study Builder Agent automates clinical study setup, cutting manual work while strengthening its connected Clinical Data ecosystem....

Veeva (VEEV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....

Standards-first agent delivers faster and more consistent EDC and DQS builds PLEASANTON, Calif., Sept. 24, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Study Builder Agent, a new AI solution that configures Veeva EDC and Veeva DQS (Data Quality System) directly......

VEEV launches Falcon Router to automate biopharma case routing, deepening AI integration across regulated life sciences workflows....

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

With 190 live customers and 14 top 20 biopharma commitments, Vault CRM is the fastest path to AI PLEASANTON, Calif., Sept. 23, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced a new top 20 biopharma commitment, adding to recent selections by Amgen, Biogen, Eli Lilly and......